Ngm Biopharmaceuticals Inc (NGM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NGM | MRNA | BMY | AMGN | GILD |
| Company | Ngm Biopharmaceuticals Inc | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.5600 | 107.43 | 47.39 | 273.45 | 67.47 |
| High | 1.5700 | 108.23 | 47.50 | 274.35 | 67.90 |
| Low | 1.5400 | 103.52 | 44.37 | 267.24 | 65.23 |
| Last | 1.5400 | 106.31 | 44.63 | 270.11 | 65.23 |
| Change | -0.0200 | -2.54 | -4.23 | -2.90 | -1.85 |
| % Change | -1.28% | -2.33% | -8.66% | -1.06% | -2.76% |
| Volume | 2,390,800 | 1,860,080 | 33,571,453 | 926,375 | 7,915,739 |
| 20-Day Average Volume | 1,155,695 | 3,088,259 | 12,231,963 | 2,103,078 | 6,482,464 |
| Previous Close | 1.5600 | 108.85 | 48.86 | 273.01 | 67.08 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5540 | 104.99 | 49.93 | 270.72 | 68.69 |
| 20-Day Raw Stochastic | 18.18% | 47.11% | 2.03% | 32.71% | 0.93% |
| 20-Day Relative Strength | 51.62% | 52.70% | 28.04% | 45.17% | 28.48% |
| Weighted Alpha | -65.03 | -11.75 | -35.01 | +9.35 | -23.62 |
| Today's Opinion | 32% Buy | 100% Buy | 88% Sell | 72% Sell | 100% Sell |
| Previous Opinion | 64% Buy | 88% Buy | 88% Sell | 40% Sell | 100% Sell |
| Last Month's Opinion | 16% Buy | 72% Buy | 8% Sell | 24% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.94% since 03/27/24 | +3.82% since 04/18/24 | -7.71% since 04/18/24 | +2.68% since 04/18/24 | -1.24% since 04/18/24 |
| Low | 1.5400 on 04/04/24 | 99.30 on 04/22/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.26 on 04/25/24 |
| High | 1.6000 on 03/28/24 | 111.29 on 04/24/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.78 on 04/25/24 |
| 1-Month | |||||
| %Chg | +1.32% since 03/04/24 | -4.06% since 03/25/24 | -14.69% since 03/25/24 | -3.92% since 03/25/24 | -9.98% since 03/25/24 |
| Low | 1.5200 on 03/11/24 | 97.00 on 04/03/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.26 on 04/25/24 |
| High | 1.6300 on 03/27/24 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | +29.41% since 01/04/24 | +3.01% since 01/25/24 | -10.15% since 01/25/24 | -13.04% since 01/25/24 | -18.56% since 01/25/24 |
| Low | 1.1800 on 01/05/24 | 84.06 on 02/13/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.26 on 04/25/24 |
| High | 2.2000 on 02/22/24 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 |
| 6-Month | |||||
| %Chg | +27.27% since 10/04/23 | +37.96% since 10/25/23 | -21.26% since 10/25/23 | -0.87% since 10/25/23 | -16.65% since 10/25/23 |
| Low | 0.6002 on 11/17/23 | 62.55 on 11/02/23 | 44.37 on 04/25/24 | 249.70 on 10/31/23 | 65.26 on 04/25/24 |
| High | 2.2000 on 02/22/24 | 115.97 on 01/08/24 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 128,531 | 41,676,488 | 99,027,448 | 146,436,016 | 83,519,768 |
| Shares Outstanding, K | 83,462 | 382,880 | 2,026,759 | 536,376 | 1,245,077 |
| Annual Sales | 4,420,000 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -142,380,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 160,000 | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 |
| Last Quarter Net Income | -27,670,000 | 217,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 |
| 60-Month Beta | 1.27 | 1.62 | 0.39 | 0.58 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.33 on 03/11/24 | 0.55 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.53 | 14.67 | 9.97 |